VELA Investment Management’s Roivant Sciences ROIV Stock Holding History

VELA Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	+5,849	New	+$173K	0.05%	160
2025 Q1	–	Sell	-69,072	Closed	-$817K	–	174
2024 Q4	$817K	Hold	69,072	–	–	0.23%	113
2024 Q3	$797K	Buy	69,072 +36,686	+113%	+$418K	0.25%	113
2024 Q2	$342K	Hold	32,386	–	–	0.11%	145
2024 Q1	$341K	Hold	32,386	–	–	0.12%	144
2023 Q4	$364K	Buy	32,386 +2,621	+9%	+$25.5K	0.14%	140
2023 Q3	$348K	Buy	29,765 +7,565	+34%	+$85.5K	0.15%	121
2023 Q2	$224K	Buy	+22,200	New	+$199K	0.1%	134

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

VELA Investment Management's ROIV Position: Q2 2026 in Review

VELA Investment Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 5,849 shares worth $207K. The stake represents 0.05% of the portfolio and ranks #160 among its holdings. This is a return to the name: VELA Investment Management previously reported a position in ROIV as recently as Q4 2024.

VELA Investment Management first reported a position in ROIV in Q2 2023 and has held it in 8 quarters since. The position peaked at $817K in Q4 2024. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

VELA Investment Management held 5,849 shares of Roivant Sciences worth $207K as of Q2 2026.
Roivant Sciences was a new VELA Investment Management position in Q2 2026.
Roivant Sciences made up 0.05% of VELA Investment Management's portfolio in Q2 2026, its #160 holding.
VELA Investment Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 8 quarters since.
VELA Investment Management's Roivant Sciences position peaked at $817K in Q4 2024.
500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.